This article was originally published in Start Up
Executive SummaryInserting foreign genes into chloroplasts--the compartments within plant cells where photosynthesis occurs--may have significant advantages over other transgenics technologies for producing therapeutic proteins. Chlorogen Inc. believes its proprietary chloroplast transformation technology will make the St. Louis start-up a player in the protein production arena.
You may also be interested in...
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.
Recent clinical data using antisense drugs in neurological diseases are encouraging signs that targeting genetic drivers of ALS with antisense oligonucleotides or other gene-altering drugs could halt progression of several forms of the disease.